Home > Boards > US OTC > Medical - Drugs >

Eastgate Biotech Corp. (ETBI)

ETBI RSS Feed
Add ETBI Price Alert      Hide Sticky   Hide Intro
Moderator: docj, Jimmy Swaggert
Search This Board: 
Last Post: 10/13/2019 11:22:27 PM - Followers: 162 - Board type: Free - Posts Today: 0

EastGate Acquisitions Corporation with locations in Salt Lake City, Utah and Toronto, Canada, is a pharmaceutical company aimed at utilizing drug delivery innovations for developing of improved novel formulations and alternative dosage forms of existing biologically active molecules.

The Company's model is based on a two-tier business approach that includes development of novel pharmaceutical products and innovative dietary supplements. Both pharmaceutical products and natural supplements are developed using highly effective contemporary technologies and demonstrated already proven usefulness in improvement of bioavailability and biological action of incorporated molecules.

The Company's product candidates address various pharmaceutical markets, including neurological disorders, such as epilepsy and panic attacks, infectious diseases and diabetes. Our natural dietary supplements, also an integral part of our R&D program, include compositions for glucose regulations, urinary tract health improvement, enhanced vitamin delivery and skin conditions.

EastGate is working to expand its current product portfolio through targeted investments in pharmaceutical research and development. We are working closely with clinicians and patient advocate groups worldwide to identify existing health issues where EastGate's approach will be most beneficial for patient care.

For more information, please visit the company's website at:  www.EastGatePharmaceuticals.com.



   



 
Contact Info
  • 2203-65 Harbour Square
    Toronto, ONT 84109
    Canada
 
Share Structure
  Market Value1 $878,295 a/o Jan 30, 2018
Authorized Shares 450,000,000 a/o Jan 02, 2018
Outstanding Shares 422,257,377 a/o Jan 02, 2018






ETBI patents:


US 61/947,678 Title: Pharmaceutical Composition for Transmucosal Delivery

US 61/947,698 Title: Treatment of Diabetes and Metabolic Syndrome

PCT/C2014/000126 Title: Pharmaceutical Composition for Transmucosal Administration of Benzodiazepines

PCT/CA2014/000127 Title: Pharmaceutical Composition For Enhanced Transmucosal Administration of Benzodiazepines





PRESS RELEASES 

http://www.eastgatebiotech.com/investors/press-releases/eastgate-biotech-announces-opening-representative-office-philippines/
http://www.eastgatebiotech.com/investors/press-releases/gunpowder-capital-corp-provides-update-eastgate/
http://www.eastgatebiotech.com/investors/press-releases/eastgate-biotech-announces-engagement-kell-group-limited-introduction-various-sources-funding-company-initiatives/
http://www.eastgatebiotech.com/investors/press-releases/omni-school-esthetics/
http://www.eastgatebiotech.com/investors/press-releases/new-independent-auditor/
http://www.eastgatebiotech.com/investors/press-releases/eastgate-biotech-engages-agent-identify-suitable-joint-venture-partners-and-suppliers-philippines/
http://www.eastgatebiotech.com/investors/press-releases/eastgate-biotech-business-turnaround-expert-bill-abajian-positive-stocks-investor-influence-network/
http://www.eastgatebiotech.com/investors/press-releases/eastgate-biotech-corp-engages-gunpowder-capital-corp/
http://www.eastgatebiotech.com/investors/press-releases/dr-ishaan-sundar-medical-director/


CHART 

ETBI
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ETBI News: Current Report Filing (8-k) 09/16/2019 11:01:37 AM
ETBI News: Termination of Registration of a Class of Security Under Section 12(g) (15-12g) 08/02/2019 03:20:09 PM
PostSubject
#12944  Sticky Note EastGate Biotech Announces Positive Phase II Clinical Results Vance 04/24/19 03:12:57 PM
#13362   YES! let’s go RussianBot 10/13/19 11:22:27 PM
#13361   Here's to another big week! GLTA! Jimmy Swaggert 10/13/19 09:22:48 PM
#13360   Thanks! Hope it works out better this time! stolles8 10/11/19 05:07:00 PM
#13359   They are paid in shares... Shares they can't Jimmy Swaggert 10/11/19 04:05:19 PM
#13358   Ask slap and we're green on the week! Jimmy Swaggert 10/11/19 03:58:07 PM
#13357   No position whatsoever. Just was worked over by tc2000chartreader 10/11/19 02:50:08 PM
#13356   Enjoy your short position when they pass phase stolles8 10/11/19 02:41:57 PM
#13355   They have $4K in the bank. Get ready tc2000chartreader 10/11/19 01:59:01 PM
#13354   They are going to bleed this company like tc2000chartreader 10/11/19 01:57:04 PM
#13353   Ummm, wow! Just $0.10 gives them each $75M. tc2000chartreader 10/11/19 01:38:29 PM
#13352   Sorry, but those are not restricted shares, so tc2000chartreader 10/11/19 01:18:44 PM
#13351   Wow, that's a huge increase in outstanding shares... tc2000chartreader 10/11/19 01:14:37 PM
#13350   Its a non-issue because unless that supply comes Chess Master 10/11/19 09:22:38 AM
#13349   This is excellent! The company is making Chess Master 10/11/19 09:20:05 AM
#13348   The only negative I see is increased outstanding stolles8 10/11/19 08:47:36 AM
#13347   Getting filed is always a good thing. This Jimmy Swaggert 10/11/19 08:12:47 AM
#13346   is this good? m00lu 10/11/19 07:26:19 AM
#13345   10K Out! Chess Master 10/11/19 02:23:54 AM
#13344   slow and steady wins the race m00lu 10/10/19 10:47:54 PM
#13343   Its looking like that's the case here! Jimmy Swaggert 10/10/19 06:44:49 PM
#13342   Yes! And when it's announced it will Jimmy Swaggert 10/10/19 05:20:12 PM
#13341   this could climb for awile leading up to m00lu 10/10/19 01:22:15 PM
#13340   You're spot on bud! There just a few Jimmy Swaggert 10/10/19 12:57:26 PM
#13339   ETBI is a major winner and EXTREMELY UNDERVALUED. Chess Master 10/10/19 12:10:21 PM
#13338   After we break. 015's a jump to .03 Jimmy Swaggert 10/10/19 12:09:24 PM
#13337   lets break the .015 mark!!! m00lu 10/10/19 10:15:35 AM
#13336   Good day! stolles8 10/09/19 10:05:41 PM
#13335   News Today! EastGate Biotech Announces Expansion and Jimmy Swaggert 10/09/19 10:10:37 AM
#13334   https://www.otcmarkets.com/stock/ETBI/news/EastGate-Biotech-Announces-Expansion- Jimmy Swaggert 10/09/19 10:08:44 AM
#13333   Love to see the slow steady increase! stolles8 10/08/19 01:52:16 PM
#13332   pre-market trading at .017? 40K volume? or is RussianBot 10/08/19 09:06:05 AM
#13331   Nothing wrong with that if you have a winner! stolles8 10/07/19 04:03:57 PM
#13330   Amen to that. I'd be happy with Jimmy Swaggert 10/07/19 03:15:36 PM
#13329   Keep trending up and I expect 1,000% increase stolles8 10/07/19 12:54:09 PM
#13328   Just another day... Watching, waiting... getting excited for Jimmy Swaggert 10/04/19 10:12:46 AM
#13327   The potential on ETBI has made this my Jimmy Swaggert 10/02/19 10:23:51 AM
#13326   Watch the bid activity early on. People Jimmy Swaggert 10/01/19 10:11:32 PM
#13325   Here we are again waiting for clinical news. Jimmy Swaggert 10/01/19 03:11:33 PM
#13324   ETBI so thin here. massivegains10 10/01/19 03:06:34 PM
#13323   I see that barchart.com has this at 100% stolles8 10/01/19 08:17:57 AM
#13322   I hope so! RussianBot 09/30/19 02:26:37 PM
#13321   Phase III should be an explosive moment for Jimmy Swaggert 09/30/19 02:24:46 PM
#13320   I remember loading up @ .004's - .005. Jimmy Swaggert 09/30/19 10:30:00 AM
#13319   Phase 3 clinical trials in progress and we massivegains10 09/28/19 12:10:35 AM
#13318   So case in point. Sell the news. Made MoMoneyLessProblems 09/27/19 02:36:13 PM
#13317   The management team is rock solid. All extremely Jimmy Swaggert 09/27/19 10:10:43 AM
#13316   It’s gone this far without being pumped - stolles8 09/27/19 08:27:44 AM
#13315   Three months in biotech for a phase III docj 09/26/19 08:01:01 PM
#13314   Phase III data still 3 months away, that's NorthShoreTrading 09/26/19 06:37:30 PM
#13313   I am not sure I have seen a docj 09/26/19 06:36:38 PM
PostSubject